Cargando…
Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data
BACKGROUND: Personalized medicine is the tailoring of treatment to the individual characteristics of patients. Once a treatment has been tested in a clinical trial and its effect overall quantified, it would be of great value to be able to use the baseline patients’ characteristics to identify patie...
Autores principales: | Bovis, Francesca, Carmisciano, Luca, Signori, Alessio, Pardini, Matteo, Steinerman, Joshua R., Li, Thomas, Tansy, Aaron P., Sormani, Maria Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580611/ https://www.ncbi.nlm.nih.gov/pubmed/31208412 http://dx.doi.org/10.1186/s12916-019-1345-2 |
Ejemplares similares
-
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis
por: Schiavetti, Irene, et al.
Publicado: (2022) -
Patterns of Comorbidity and In-Hospital Mortality in Older Patients With COVID-19 Infection
por: Mahmoud, Mona, et al.
Publicado: (2021) -
Quantitative assessment of finger motor performance: Normative data
por: Signori, Alessio, et al.
Publicado: (2017) -
Modeling the Distribution of New MRI Cortical Lesions in Multiple Sclerosis Longitudinal Studies
por: Sormani, Maria Pia, et al.
Publicado: (2011) -
Sacubitril/valsartan in real‐life European patients with heart failure and reduced ejection fraction: a systematic review and meta‐analysis
por: Giovinazzo, Stefano, et al.
Publicado: (2021)